Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Tadros, Manal ^a   Williams, Victoria ^b   Coleman, Brenda L ^a,c   McGeer, Allison J ^a,c   Haider, Shariq ^d   Lee, Christine ^e   Iacovides, Harris ^f   Rubinstein, Ethan ^f   John, Michael ^g   Johnston, Lynn ^h   McNeil, Shelly ^h   Katz, Kevin ⁱ   Laffin, Nancy ^j   Suh, Kathryn N ^j   Powis, Jeff ^a,k   Smith, Stephanie ^l   Taylor, Geoff ^l   Watt, Christine ^b   Simor, Andrew E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f HEALTH SCIENCES CENTRE   (Canada)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ NORTH YORK GENERAL HOSPITAL   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

^k TORONTO EAST GENERAL HOSPITAL   (Canada)

^l UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SURVEILLANCE; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PNEUMONIA; PROGNOSIS; RISK FACTOR; STAPHYLOCOCCAL PNEUMONIA; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CAUSE OF DEATH; COMORBIDITY; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PNEUMONIA, STAPHYLOCOCCAL; PROSPECTIVE STUDIES; PUBLIC HEALTH SURVEILLANCE; YOUNG ADULT;

EID: 84884251662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075171     Document Type: Article

References (39)

1. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, et al. (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 854-862. PubMed: 16354854.
2. Rubinstein E, Kollef MH, Nathwani D, (2008) Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 (Suppl. 5)():: S378-S385. doi:10.1086/533594. PubMed: 18462093.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, et al. (2012) Prevalence of methicillin-resistant Staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 54: 1126-1133. doi:10.1093/cid/cis022. PubMed: 22438343.
4. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, et al. (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin gene. Clin Infect Dis 40: 100-107. doi:10.1086/427148. PubMed: 15614698.
5. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, et al. (2006) Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12: 894-899. doi:10.3201/eid1206.051141. PubMed: 16707043.
6. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, et al. (2009) Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 53: 358-365. doi:10.1016/j.annemergmed.2008.04.027. PubMed: 18534715.
7. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, et al. (2006) Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 10: R97. doi:10.1186/cc4934. PubMed: 16808853.
8. Shorr AF, Haque N, Taneja C, Zervos M, Lamerato L, et al. (2010) Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol 48: 3258-3262. doi:10.1128/JCM.02529-09. PubMed: 20631118.
9. Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, et al. (2012) Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. J Clin Microbiol 50: 1640-1644. doi:10.1128/JCM.06701-11. PubMed: 22337980.
10. Bouza E, Giannella M, Bunsow E, Torres MV, Granda MJ, et al. (2012) Ventilator-associated pneumonia due to meticillin-resistant Staphylococcus aureus: risk factors and outcome in a large general hospital. J Hosp Infect 80: 150-155. doi:10.1016/j.jhin.2011.11.013. PubMed: 22226126.
11. Haque NZ, Zuniga LC, Peyrani P, Reyes K, Lamerato L, et al. (2010) Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Chest 138: 1356-1362. doi:10.1378/chest.09-2453. PubMed: 20558550.
12. Choi EY, Huh JW, Lim CM, Koh Y, Kim SH, et al. (2011) Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med 37: 639-647. doi:10.1007/s00134-011-2130-7. PubMed: 21253703.
13. Peyrani P, Allen M, Wiemken TL, Haque NZ, Zervos MJ, et al. (2011) Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis 53: 766-771. doi:10.1093/cid/cir541. PubMed: 21880581.
14. Sharma-Kuinkel BK, Ahn SH, Rude TH, Zhang Y, Tong SYC, et al. (2012) Presence of genes encoding Panton-Valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus. J Clin Microbiol 50: 848-856. doi:10.1128/JCM.06219-11. PubMed: 22205797.
15. van Hal SJ, Paterson DL, (2011) Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother; 55: 405-410. doi:10.1128/AAC.01133-10. PubMed: 21078939.
16. Horan TC, Andrus M, Dudeck MA, (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36: 309-332. doi:10.1016/j.ajic.2008.03.002. PubMed: 18538699.
17. American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171: 388-416. doi:10.1164/rccm.200405-644ST. PubMed: 15699079.
18. Simor AE, Gilbert NL, Gravel D, Mulvey MR, Bryce E, et al. (2010) Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: national surveillance and changing epidemiology, 1995-2007. Infect Control Hosp Epidemiol 31: 348-356. doi:10.1086/651313. PubMed: 20148693.
19. Tsai Y-F, Ku Y-H, (2012) Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration. Curr Opin Pulm Med 18: 246-252. doi:10.1097/MCP.0b013e3283521022. PubMed: 22388585.
20. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, et al. (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary. Clin Infect Dis 52: 285-292. doi:10.1093/cid/cir034. PubMed: 21217178.
21. Louie L, Goodfellow J, Mathieu P, Glatt A, Louie M, et al. (2002) Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol 40: 2786-2790. doi:10.1128/JCM.40.8.2786-2790.2002. PubMed: 12149330.
22. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. M100-MS22 Wayne, PA: Clinical and Laboratory Standards Institute. PubMed: 22476137.
23. Christianson S, Golding GR, Campbell J, the Canadian Nosocomial Infection Surveillance Program, Mulvey MR, (2007) Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45: 1904-1911. doi:10.1128/JCM.02500-06. PubMed: 17428941.
24. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, et al. (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29: 1128-1132. doi:10.1086/313461. PubMed: 10524952.
25. Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, et al. (2006) Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 130: 947-955. doi:10.1378/chest.130.4.947. PubMed: 17035423.
26. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, et al. (2010) Health care-associated invasive MRSA infections, 2005-2008. JAMA 304: 641-648. doi:10.1001/jama.2010.1115. PubMed: 20699455.
27. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, et al. (2012) Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 67: 802-809. doi:10.1093/jac/dkr561. PubMed: 22223229.
28. Klein E, Smith DL, Laxminarayan R, (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13: 1840-1846. doi:10.3201/eid1312.070629. PubMed: 18258033.
29. Moalla M, Baratin D, Giarrd H, Vanhems P, (2008) Incidence of methicillin-resistant Staphylococcus aureus nosocomial infections in intensive care units in Lyon University Hospitals, France, 2003-2006. Infect Control Hosp Epidemiol 29: 454-456.
30. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN Annual Update. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011. doi:10.1086/591861. PubMed: 18947320.
31. Lobo LJ, Reed KD, Wunderink RG, (2010) Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 138: 130-136. PubMed: 20173050.
32. Vardakas KZ, Matthaiou DK, Falagas ME, (2009) Incidence, characteristics and outcomes of patients with severe community-acquired MRSA pneumonia. Eur Respir J 34: 1148-1158. doi:10.1183/09031936.00041009. PubMed: 19541719.
33. Mendes RE, Deshpande LM, Smyth DS, Shopsin B, Farrell DJ, et al. (2012) Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia. J Clin Microbiol 50: 3694-3702. doi:10.1128/JCM.02024-12. PubMed: 22972817.
34. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, et al. (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54: 621-629. doi:10.1093/cid/cir895. PubMed: 22247123.
35. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, et al. (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978-984. doi:10.3201/eid0908.030089. PubMed: 12967497.
36. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359: 753-759. doi:10.1016/S0140-6736(02)07877-7. PubMed: 11888586.
37. Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC, (2013) The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 13: 43-54. doi:10.1016/S1473-3099(12)70238-4. PubMed: 23103172.
38. van Hal SJ, Lodise TP, Paterson DL, (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54: 755-771. doi:10.1093/cid/cir935. PubMed: 22302374.
39. DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS, (2005) Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 128: 1414-1422. doi:10.1378/chest.128.3.1414. PubMed: 16162737.